Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population.
D000367:Age Factors; D000906:Antibodies / Q000032:analysis; D002140:California; D002648:Child; D002675:Child, Preschool; D003168:Complement Fixation Tests; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D008297:Male; D009976:Orthomyxoviridae Infections / Q000453:epidemiology / Q000517:prevention & control*; D018184:Paramyxoviridae Infections / Q000453:epidemiology / Q000517:prevention & control; D011159:Population Surveillance; D012136:Respiratory Syncytial Viruses / Q000276:immunology; D012141:Respiratory Tract Infections / Q000453:epidemiology / Q000517:prevention & control*; D018108:Respirovirus / Q000276:immunology; D012621:Seasons; D014611:Vaccination; D014765:Viral Vaccines
D000906:Antibodies; D014765:Viral Vaccines